⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CORT News
Corcept Therapeutics Inc.
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
accessnewswire.com
CORT
Pomerantz LLP Alerts Shareholders to Investor Suit Against Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
Contact Levi & Korsinsky by April 21, 2026 Deadline to Join Class Action Against Corcept Therapeutics Incorporated(CORT)
globenewswire.com
CORT
Contact Levi & Korsinsky by April 21, 2026 Deadline to Join Class Action Against Corcept Therapeutics Incorporated(CORT)
globenewswire.com
CORT
Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline
globenewswire.com
CORT
Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline
globenewswire.com
CORT
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
CORT
Pomerantz LLP Advises Shareholders of Class Action Involving Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
CORT
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
CORT